+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Diabetic Neuropathy Drug"

From
From
From
From
From
From
From
From
Diabetic Peripheral Neuropathy Global Clinical Trials Review, H1, 2020 - Product Thumbnail Image

Diabetic Peripheral Neuropathy Global Clinical Trials Review, H1, 2020

  • Clinical Trials
  • June 2020
  • 182 Pages
  • Global
From
From
Diabetic Peripheral Neuropathy - Pipeline Review, H2 2020 - Product Thumbnail Image

Diabetic Peripheral Neuropathy - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 97 Pages
  • Global
From
From
Diabetic Neuropathy - Pipeline Review, H2 2020 - Product Thumbnail Image

Diabetic Neuropathy - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 143 Pages
  • Global
From
Loading Indicator

Diabetic Neuropathy Drug is a type of Central Nervous System (CNS) drug used to treat nerve damage caused by diabetes. It works by blocking the transmission of pain signals from the nerves to the brain. Commonly used drugs include anticonvulsants, antidepressants, and opioids. These drugs can help reduce pain, improve sleep, and improve quality of life. Side effects may include drowsiness, dizziness, and nausea. The Diabetic Neuropathy Drug market is a rapidly growing segment of the CNS drug market. It is driven by the increasing prevalence of diabetes, as well as the need for effective treatments for diabetic neuropathy. The market is expected to continue to grow in the coming years, as new treatments are developed and approved. Some companies in the Diabetic Neuropathy Drug market include Pfizer, Novartis, Merck, and GlaxoSmithKline. Show Less Read more